Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DAK |
| Upstream (Parents) |
|---|
| (<<) GSTZ1 → DAK |
| (<<) ZGPAT → DAK |
| (<<) SLC37A4 → DAK |
| (<<) PCK2 → DAK |
| Downstream (Children) |
|---|
| DAK → EYA1 (>>) |
| DAK → SLC30A6 (>>) |
| DAK → HNF4A (>>) |
| DAK → HDAC6 (>>) |
| DAK → CYP2A13 (>>) |
| DAK → GPR182 (>>) |
| DAK → NEU2 (>>) |
| DAK → RAGE (>>) |
| DAK → RHBG (>>) |
| DAK → PGAP3 (>>) |
| DAK → FADS1 (>>) |
| DAK → LIPG (>>) |
| DAK → SREBF1 (>>) |
